Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
umbilical cord mesenchymal stem cells (3 trials)
allogeneic adipose derived mesenchymal stem cell (2 trials)
autologous mesenchymal stem cells (1 trial)
autologous mononuclear stem cell (1 trial)
bone marrow derived mesenchymal stem cells (1 trial)
Graft vs Host Disease (Phase 2)
Infarction (Phase 2)
Infarction, Middle Cerebral Artery (Phase 2)
Ischemia (Phase 2)
Osteoarthritis (Phase 2)
Trials (7 total)
Trial APIs (5 total)